Home » Topics » BioWorld Science

BioWorld Science
RSS

Oncostatin M targeting as approach for treating inflammatory pruritus

Nov. 30, 2021

Blueprint Medicines to acquire LNG-451 with Lengo Therapeutics acquisition

Nov. 30, 2021

HotSpot Therapeutics closes financing to support Smart Allostery-driven pipeline

Nov. 29, 2021

Turnstone Biologics collaborates with Moffitt on preclinical TIL therapies

Nov. 29, 2021

Genmab presents preclinical data for DuoBody-CD3xB7H4 (GEN-1047)

Nov. 29, 2021

Novel silicon-containing cannabinoids show therapeutic efficacy in model of multiple sclerosis

Nov. 29, 2021

M-9657 shows mesothelin-dependent antitumoral activity in vivo

Nov. 29, 2021

Discovery of the novel BCL6 BTB-specific inhibitor, AP-4-287

Nov. 29, 2021

Targeting senescent cells may fight insulin resistance

Nov. 29, 2021

KCC2 shows promise as therapeutic target for neonatal seizures

Nov. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...